Published by Global Banking & Finance Review

Posted on November 13, 2026

· Last updated: November 13, 2026

Soros Fund Management Increases Intel Stake to Over $340 Million in Q3

Soros Fund Management's Strategic Moves in Q3 2023

Significant Increase in Intel Holdings

Nov 13 (Reuters) - Soros Fund Management, the family office of billionaire George Soros, significantly raised its stake in Intel in the third quarter, a regulatory filing showed on Friday.

Here are more details:

• The investment firm built a 2.83 million-share position valued at $340.3 million as it boosted its exposure to the major PC chip supplier

• The fund had held just 100,000 Intel shares at the end of June, according to its previous quarterly disclosure, marking one of the most striking changes in its portfolio

• Intel's stock took a hammering late last month after the chipmaker warned of a severe cash burn this year due to the faltering PC market, bottlenecks in manufacturing ‌and heavy spending on expanding production

• Still, the stock is up nearly 62% year to date, as the company benefits from surging demand for AI data-center CPUs

• The fund cut its stake in Apple by 25.7% to 393,680 shares and in ON Semiconductor by 92.7% to 16,594 shares

• The disclosures on Friday were made through the so-called 13F regulatory filings, which show investment firms' portfolios and are closely watched for trends even though the data is released with a delay

(Reporting by Pritam Biswas in Bengaluru; Editing by Sriraj Kalluvila)

Key Takeaways

  • Soros Fund Management went from a modest new position in Intel (~$14 million, 100,000 shares) in Q2 to a substantial ~2.83 million‑share stake worth ~$340 million in Q3 2026 (Reuters; SEC filings)
  • Intel’s stock, despite a recent sharp drop following warnings of severe cash burn, is up ~62% year‑to‑date thanks to booming AI data‑center CPU demand (Reuters)
  • Concurrently, Soros Fund reduced stakes in Apple (−25.7%) and ON Semiconductor (−92.7%), per the Q3 13F filing—highlighting a strategic repositioning amid sector volatility and AI tailwinds

Frequently Asked Questions

Tags

Related Articles

Weil, Gotshal & Manges approves liquidation plan, begins wind-down

AstraZeneca cuts 600 sales jobs in US, Bloomberg News reports

Exclusive-Brookfield, CPPIB consortium enters next round in Uniper sales process, sources say

Dutch government coalition averts collapse, Dutch media report

Russia's Sibur calls UK sanctions illegitimate, reserves right to challenge them

Novo Holdings-backed Windward Bio valued at $1 billion as shares rise in Nasdaq debut

More from Finance

Explore more articles in the Finance category